Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of endothelium corneum gigeriae galli and salviae miltiorrhizae capsules for preparing medicines for relieving asthma

A technology of Jinshen Shugan capsule and anti-asthma, applied in the directions of capsule delivery, drug combination, pharmaceutical formula, etc., can solve the problem of untreated asthma, etc., and achieve good results

Inactive Publication Date: 2014-01-01
THE FIRST AFFILIATED HOSPITAL OF XINXIANG MEDICAL UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Jinshen Shugan Capsule is an exclusive product of Harbin Shengtai Pharmaceutical Co., Ltd., and there is no literature report on its treatment of asthma

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of endothelium corneum gigeriae galli and salviae miltiorrhizae capsules for preparing medicines for relieving asthma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0008] Experimental Research Data of Jinshen Shugan Capsules in Treating Asthma

[0009] 1. Research drug: Jinshen Shugan Capsule, Harbin Shengtai Pharmaceutical Co., Ltd., batch number: 20110424

[0010] 2. Animals: guinea pigs, half male and half male, weighing about 160-200g, provided by Qinglongshan Animal Breeding Farm, Tangshan, Jiangning County, experimental animal production license SCXK (Su) 2002-0004, experimental animal use license: SYXK (Su) 2002 -0008.

[0011] 3. Reagents: acetylcholine chloride (Shanghai Sanaisi Reagent Co., Ltd., batch number: 20080527), histamine phosphate (sigma, batch number: 31K2615).

[0012] 4. Method: The day before the experiment, the guinea pigs were screened in advance, and the guinea pigs were sprayed with an equal volume mixture of 2% acetylcholine chloride and 0.1% phosphate histamine for 15 seconds, and the incubation period of the guinea pigs was observed (that is, from the beginning of spraying to the onset of asthma, breathing...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of endothelium corneum gigeriae galli and salviae miltiorrhizae capsules for preparing medicines for relieving asthma. The formula of the endothelium corneum gigeriae galli and salviae miltiorrhizae capsules comprises the components of astragalus, suis fellis pulvis, cornu bubali concentrated powder, radix bupleuri, oldenlandia diffusa, fructus aurantii, fructus schizandrae, fructus ligustri lucidi, polygonum cuspidatum, endothelium corneum gigeriae galli, salviae miltiorrhizae, and radix curcumae which are prepared into capsules; the capsules can enhance the immune function of a human body and improve the anti-virus capability of the human body; the hepatitis B virus can be effectively suppressed, the liver repair is promoted, the overall function of the liver is improved, the liver pain is relieved, and the hepatosplenomegaly is eliminated; and moreover, the capsules can replenish qi and blood, the both symptoms and root causes are treated, and the capsules can relieve asthma.

Description

technical field [0001] The invention relates to a new application of a Chinese patent medicine, in particular to the application of Jinshen Shugan Capsules in preparing antiasthmatic medicines. Background technique [0002] Risk factors for the onset of asthma include host factors (genetic factors) and environmental factors. Genetic factors can be reflected in many patients. For example, among the relatives of the vast majority of patients (blood relationship, nearly three generations), it can be traced back to asthma (repeated coughing, wheezing) or other allergic diseases (allergic rhinitis) , atopic dermatitis) medical history. Most asthmatics are allergic and may have allergic rhinitis and / or atopic dermatitis themselves, or are sensitive to common airborne allergens (mites, pollens, pets, molds, etc.), certain foods (nuts, Milk, peanuts, seafood, etc.), drug allergies, etc. [0003] The pathogenesis of asthma is still not fully understood, including: allergy, chronic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/9066A61K9/48A61P11/06A61K35/413A61K35/37A61K35/32A61K35/57
Inventor 臧莉杨玉新冯辉秦瑞英徐莉郭晓亮马丽娟
Owner THE FIRST AFFILIATED HOSPITAL OF XINXIANG MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com